Article Details

Vaxart Phase 1b Trial Shows 100% Increase in Serum Anti-VP1 IgA in Elderly Adults with ...

Retrieved on: 2025-03-06 16:30:50

Tags for this article:

Click the tags to see associated articles and topics

Vaxart Phase 1b Trial Shows 100% Increase in Serum Anti-VP1 IgA in Elderly Adults with .... View article details on hiswai:

Excerpt

BioNTech's malaria vaccine initiative was first announced in 2021, using the same mRNA technology that powered its successful COVID-19 vaccine. The ...

Article found on: www.contagionlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo